MADISON,
Wis., June 20, 2024 /PRNewswire/ -- Accuray
Incorporated (NASDAQ: ARAY) announced today an agreement with
TrueNorth Medical Physics LLC to provide radiation oncology
departments with third-party support designed to enhance their
department's capabilities. Under the terms of the agreement,
TrueNorth Medical Physics will offer services that are
complementary and supplementary to those supplied by Accuray,
acting as an extension of the hospital team – on-site, remote or
hybrid – to help ensure they have the staffing needed to achieve
patient treatment goals.
As the field of radiation medicine has evolved since the X-ray
was discovered 125+ years ago, so too has the TrueNorth team which
now has an equivalent number of combined clinical years of
experience. They will leverage this vast knowledge base to provide
physics, dosimetry and commissioning support for the Accuray
TomoTherapy®, Radixact® and
CyberKnife® Systems. TrueNorth offers specialized
services that help augment a hospital's team and are tailored to
their specific requirements. From providing additional staff while
the site recruits new personnel or when only part-time assistance
is desired, to sharing expertise that facilitates adoption of new
technology and techniques, the company is equipped to meet these
needs.
"We are excited about the opportunity to partner with Accuray
and assist their customers. We have extensive experience working
with Accuray's Radixact, TomoTherapy and CyberKnife platforms and
are impressed with the unique features and associated benefits they
provide," said Matt Daniels, Ph.D.,
DABR, one of the TrueNorth Managing Partners. "Nevertheless, we are
an independent company with expertise across multiple industry
platforms. Our organization is dedicated to providing unbiased
feedback and support that improves the practice of radiation
therapy medicine and enhances a team's ability to deliver
care."
The addition of the TrueNorth offerings signifies a commitment
from Accuray to provide an expanded range of solutions to help
empower medical professionals from day one and throughout their
tenure using the company's technology. The assistance they require
will vary based on their clinical and economic goals, experience,
and equipment age. Accuray offers a combination of standard and
customizable services to align with differing preferences and
circumstances, aimed at helping clinicians to deliver the best
possible outcomes for patients.
"Accuray is committed to innovation in every aspect of our
business, whether it be the radiotherapy technology we develop or
the support we provide to customers to help them achieve their
patient-focused treatment objectives," said Suzanne Winter, president and CEO of Accuray.
"In today's dynamic and evolving healthcare environment, labor
shortages and operational challenges may hinder hospitals from
maintaining the staffing levels needed to meet their clinical
demands and standards. We partnered with TrueNorth Medical
Physics to provide care teams with another option for obtaining the
resources they require to advance the treatment of cancer for more
patients within their facilities."
About Accuray
Accuray is committed to expanding the powerful potential of
radiation therapy to improve as many lives as possible. We invent
unique, market-changing solutions that are designed to deliver
radiation treatments for even the most complex cases—while making
commonly treatable cases even easier—to meet the full spectrum of
patient needs. We are dedicated to continuous innovation in
radiation therapy for oncology, neuro-radiosurgery, and beyond, as
we partner with clinicians and administrators, empowering them to
help patients get back to their lives, faster. Accuray is
headquartered in Madison,
Wisconsin, with facilities worldwide. To learn more, visit
www.accuray.com or follow us on Facebook, LinkedIn, Twitter, and
YouTube.
Safe Harbor Statement
Statements made in this press release that are not statements of
historical fact are forward-looking statements and are subject to
the "safe harbor" provisions of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements in this press
release relate, but are not limited to, expectations regarding the
offerings provided by TrueNorth and the partnership with TrueNorth.
These risks and uncertainties include, but are not limited to, the
effect of the current global economic environment, including in
connection to the COVID-19 pandemic, on the operations of the
company and those of its customers and suppliers; the company's
ability to achieve widespread market acceptance of its products and
offerings; the company's ability to develop new products and
offerings or improve existing products and offerings to meet
customers' needs; the company's ability to anticipate or keep pace
with changes in the marketplace and the direction of technological
innovation and customer demands; reliance on third party
collaborators, partnerships, strategic alliances and joint
ventures; and such other risks identified under the heading "Risk
Factors" in the company's quarterly report on Form 10-Q, filed with
the Securities and Exchange Commission (the "SEC") on May 8, 2024, and as updated periodically with the
company's other filings with the SEC.
Forward-looking statements speak only as of the date the
statements are made and are based on information available to the
company at the time those statements are made and/or management's
good faith belief as of that time with respect to future events.
The company assumes no obligation to update forward-looking
statements to reflect actual performance or results, changes in
assumptions or changes in other factors affecting forward-looking
information, except to the extent required by applicable securities
laws. Accordingly, investors should not put undue reliance on any
forward-looking statements.
Media Contact
Beth Kaplan
Public Relations Director, Accuray
Phone +1 (408) 789-4426
Email: bkaplan@accuray.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/accuray-and-truenorth-medical-physics-sign-agreement-to-provide-radiation-oncology-support-intended-to-advance-cancer-care-for-more-patients-302176452.html
SOURCE Accuray Incorporated